SRTS

Sensus Healthcare, Inc. (SRTS) ESG Analysis Analysis (2026)

Invetso Score: 6.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 6.4 (Moderate)

R&D intensity of 36.6% of revenue suggests a technology-led product mix that can support lower operational footprint than more manufacturing-heavy peers, though disclosure is limited.

Very low debt-to-equity of 0.01 reduces balance-sheet pressure that can otherwise constrain environmental capex, but peers with stronger sustainability reporting remain more transparent.

Gross margin of 36.4% implies some pricing room to absorb compliance and efficiency investments, yet the absence of emissions, energy, or waste metrics limits peer-relative confidence.

No direct environmental controversy or regulatory disclosure is provided, so the company appears neither advantaged nor disadvantaged versus peers on available evidence.

Social

Score:

Stock-based compensation at 1.7% of revenue indicates limited dilution pressure, which can support employee alignment, but it does not by itself demonstrate stronger labor practices than peers.

High R&D spend relative to revenue can indicate greater reliance on specialized talent, which may strengthen human-capital intensity versus peers, although retention and safety data are unavailable.

The provided metrics do not include workforce, customer, or product-safety indicators, so social assessment remains constrained relative to peers with fuller disclosure.

No material social controversy is evident in the supplied data, but the lack of third-party metrics prevents a stronger relative score versus better-disclosed peers.

Governance

Score:

Debt-to-equity of 0.01 suggests conservative capital structure, which typically reduces creditor-driven governance pressure versus more levered peers.

Stock-based compensation of 1.7% of revenue appears contained, supporting cleaner capital allocation and lower dilution risk than peers with heavier equity compensation.

R&D intensity of 36.6% of revenue implies disciplined reinvestment in product development, but governance quality cannot be fully assessed without board, audit, and ownership disclosures.

No evidence of severe governance controversy is provided, so the company screens better than many peers on available capital-discipline indicators.

Overall Score

Score:

Available metrics suggest a generally disciplined profile with limited leverage and contained dilution, but sparse ESG disclosure keeps relative positioning below stronger-disclosed peers.

Score Driver: Limited ESG Disclosure Across Environmental And Social Metrics

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Sensus Healthcare, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →